Novo Nordisk’s Wegovy and copyright, both equally run by semaglutide, have revolutionized obesity treatment method by means of unprecedented weight loss success.In Oct 2024, Novo Nordisk printed a analyze on scientific journal Mother nature a few novel glucose-delicate insulin NNC2215 which will decrease the chance of hypoglycemia in animal style